{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:25:09Z","timestamp":1790083509271,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","award":["3032"],"award-info":[{"award-number":["3032"]}],"id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics","doi-asserted-by":"publisher","award":["HU15XX0"],"award-info":[{"award-number":["HU15XX0"]}],"id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.omtn.2018.10.015","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T21:51:07Z","timestamp":1540849867000},"page":"699-709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Overcoming the Undesirable CRISPR-Cas9 Expression in Gene Correction"],"prefix":"10.1016","volume":"13","author":[{"given":"Emily","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongqi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fushan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle E.","family":"Seigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Grasemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2018.10.015_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0092-8674(93)80063-K","article-title":"Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis","volume":"75","author":"Zabner","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2018.10.015_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ng0994-42","article-title":"Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis","volume":"8","author":"Crystal","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2018.10.015_bib3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJM199509283331302","article-title":"A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis","volume":"333","author":"Knowles","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2018.10.015_bib4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/S0140-6736(05)77740-0","article-title":"Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus","volume":"351","author":"Wagner","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2018.10.015_bib5","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1089\/104303401750298535","article-title":"Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications","volume":"12","author":"Joseph","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2018.10.015_bib6","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1089\/104303401750298544","article-title":"Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium","volume":"12","author":"Perricone","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2018.10.015_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/vim.2004.17.327","article-title":"Adenoviral vectors for gene replacement therapy","volume":"17","author":"Cao","year":"2004","journal-title":"Viral Immunol."},{"key":"10.1016\/j.omtn.2018.10.015_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.gendis.2014.06.001","article-title":"Lung gene therapy\u2014How to capture illumination from the light already present in the tunnel","volume":"1","author":"Xia","year":"2014","journal-title":"Genes Dis."},{"key":"10.1016\/j.omtn.2018.10.015_bib9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1183\/09031936.00017007","article-title":"Antimicrobial peptides in the real world: implications for cystic fibrosis","volume":"29","author":"Hiemstra","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.omtn.2018.10.015_bib10","first-page":"535","article-title":"The mucosal immunologic network","volume":"53","author":"Bienenstock","year":"1984","journal-title":"Ann. Allergy"},{"key":"10.1016\/j.omtn.2018.10.015_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1745-6150-1-7","article-title":"A\u00a0putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action","volume":"1","author":"Makarova","year":"2006","journal-title":"Biol. Direct"},{"key":"10.1016\/j.omtn.2018.10.015_bib12","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/ncomms4157","article-title":"Genotyping with CRISPR-Cas-derived RNA-guided endonucleases","volume":"5","author":"Kim","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2018.10.015_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s13238-014-0032-5","article-title":"Homologous recombination in human embryonic stem cells using CRISPR\/Cas9 nickase and a long DNA donor template","volume":"5","author":"Rong","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.omtn.2018.10.015_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1242\/dev.103341","article-title":"Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells","volume":"141","author":"Kearns","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.omtn.2018.10.015_bib15","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1534\/genetics.113.152710","article-title":"Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease","volume":"194","author":"Gratz","year":"2013","journal-title":"Genetics"},{"key":"10.1016\/j.omtn.2018.10.015_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/cr.2013.45","article-title":"Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos","volume":"23","author":"Chang","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.omtn.2018.10.015_bib17","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","article-title":"One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering","volume":"153","author":"Wang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2018.10.015_bib18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.cell.2014.01.027","article-title":"Generation of gene-modified cynomolgus monkey via Cas9\/RNA-mediated gene targeting in one-cell embryos","volume":"156","author":"Niu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2018.10.015_bib19","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/cr.2013.141","article-title":"Heritable gene-targeting with gRNA\/Cas9 in rats","volume":"23","author":"Hu","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.omtn.2018.10.015_bib20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2018.10.015_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/mt.2009.277","article-title":"Gene therapy for Leber\u2019s congenital amaurosis is safe and effective through 1.5 years after vector administration","volume":"18","author":"Simonelli","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.10.015_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","article-title":"Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years","volume":"130","author":"Jacobson","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.omtn.2018.10.015_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/gt.2012.43","article-title":"Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial","volume":"20","author":"Gaudet","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2018.10.015_bib24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.117.310996","article-title":"In\u00a0vivo genome editing restores dystrophin expression and cardiac function in dystrophic mice","volume":"121","author":"El Refaey","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtn.2018.10.015_bib25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nm.4367","article-title":"Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism","volume":"23","author":"Kemaladewi","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2018.10.015_bib26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.addr.2006.03.007","article-title":"Current status of polymeric gene delivery systems","volume":"58","author":"Park","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2018.10.015_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/hum.2017.201","article-title":"Transducing airway basal cells with a helper-dependent adenoviral vector for lung gene therapy","volume":"29","author":"Cao","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2018.10.015_bib28","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ymthe.2003.08.014","article-title":"Improved system for helper-dependent adenoviral vector production","volume":"8","author":"Palmer","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.10.015_bib29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2018.10.015_bib30","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.1128\/JVI.00796-09","article-title":"Host cell detection of noncoding stuffer DNA contained in helper-dependent adenovirus vectors leads to epigenetic repression of transgene expression","volume":"83","author":"Ross","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2018.10.015_bib31","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nbt.3190","article-title":"Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining","volume":"33","author":"Maruyama","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2018.10.015_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/mthe.2000.0135","article-title":"Targeting transgene expression to airway epithelia and submucosal glands, prominent sites of human CFTR expression","volume":"2","author":"Chow","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.10.015_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2018.10.015_bib34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2018.10.015_bib35","article-title":"Identification of pre-existing adaptive immunity to Cas9 proteins in humans","author":"Charlesworth","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2018.10.015_bib36","doi-asserted-by":"crossref","first-page":"15364","DOI":"10.1073\/pnas.2436478100","article-title":"Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia","volume":"100","author":"Koehler","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.10.015_bib37","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1073\/pnas.97.3.1002","article-title":"Optimization of the helper-dependent adenovirus system for production and potency in\u00a0vivo","volume":"97","author":"Sandig","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.10.015_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ijc.2910170110","article-title":"A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells","volume":"17","author":"Lieber","year":"1976","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtn.2018.10.015_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1165\/ajrcmb\/4.4.313","article-title":"A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection","volume":"4","author":"Zeitlin","year":"1991","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.omtn.2018.10.015_bib40","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1093\/nar\/23.24.5087","article-title":"A simple, rapid method for isolation of high quality genomic DNA from animal tissues","volume":"23","author":"Wu","year":"1995","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118302865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118302865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:23:34Z","timestamp":1762601014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253118302865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":40,"alternative-id":["S2162253118302865"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2018.10.015","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming the Undesirable CRISPR-Cas9 Expression in Gene Correction","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2018.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors.","name":"copyright","label":"Copyright"}]}}